FIGURE 7.
Mutation in the WH2-like sequence FH2-independent elongation inhibition. A, raw curves from filament elongation assays using 3.1 μm polymerized actin, 1 μm actin monomers (25% pyrene), and 6.25 nm concentrations of the indicated constructs. B, inhibition of filament elongation by the indicated FFC mutant constructs.